Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06085300 · ClinicalTrials.gov registry record · NA
The Relationship Between Child Language Proficiency and Language of Treatment on the Outcomes of Bilingual Children with Developmental Language Disorder
A NA study of Developmental Language Disorder and Language Impairment, sponsored by University of Houston.
- Recruiting
- Registry status
- NA
- Development phase
- 120
- Enrollment target
- 1
- Study location
NCT06085300: Recruiting NA study of Developmental Language Disorder and Language Impairment, sponsored by University of Houston.
NCT06085300 is a NA study of Developmental Language Disorder and Language Impairment that is actively recruiting participants, run by University of Houston. The registered enrollment target is 120 participants, below the 176-participant average among 17 other Developmental Language Disorder trials with a reported enrollment target (32% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06085300, a NA study of Developmental Language Disorder and Language Impairment, is actively recruiting participants, sponsored by University of Houston.
- RECRUITING
- Registry status
- NA
- Development phase
- 120 participants
- Enrollment target
- 1
- Study location
Study Summary
Of the 12 million children in the USA growing up bilingual, about 1 million experience Developmental Language Disorder (DLD), a disorder in language learning and use. Currently there is no guidance for speech language pathologists (SLPs) as to the language of intervention for bilingual children with DLD with differing degrees of proficiency with English or Spanish. This project will examine the relationship between relative language proficiency and the language of intervention, considering monolingual intervention in English and Spanish and bilingual intervention presented by alternating English and Spanish treatment sessions with the goal of improving language outcomes and thereby strengthening long-term academic achievement.
Primary Outcome
Accuracy on elicited production probes are the primary outcome measure. There are 40 probes in total. Ten for Spanish conditionals, ten English conditionals, ten Spanish complement clauses and ten English complement clauses.
Conditions Studied
Interventions
- BEHAVIORAL Sentence recast
Study Locations (1)
Texas
- School Districst - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2023-08-08 |
| Est. Completion | 2028-05-01 |
| Phase | NA |
What NCT06085300 shows while recruiting
NCT06085300 is an interventional study that assigns participants to a tested intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, below the 176-participant average among 17 other Developmental Language Disorder trials with a reported enrollment target (32% lower).
The record links to 2 conditions, with Developmental Language Disorder appearing as the primary indexed condition, and to 1 intervention - of which Sentence recast is the first listed.
NCT06085300 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT06085300 about?
NCT06085300 is a clinical study titled "The Relationship Between Child Language Proficiency and Language of Treatment on the Outcomes of Bilingual Children with Developmental Language Disorder". Of the 12 million children in the USA growing up bilingual, about 1 million experience Developmental Language Disorder (DLD), a disorder in language learning and use. Currently there is no guidance for speech language pathologists (SLPs) as to the language of intervention for bilingual children with...
What is the current status of trial NCT06085300?
This trial is currently recruiting. It is a NA study. The enrollment target is 120 participants. The study started on 2023-08-08. Estimated completion is 2028-05-01.
What conditions does trial NCT06085300 study?
This clinical trial studies the following conditions: Developmental Language Disorder, Language Impairment.
What interventions are being tested in trial NCT06085300?
The interventions under investigation include: Sentence recast (BEHAVIORAL).
Who is sponsoring clinical trial NCT06085300?
This trial is sponsored by University of Houston, which has 64 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06085300 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Developmental Language Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06085300's enrollment target sits among peer trials
120 7th of 17 higher than 10 of 17 other Developmental Language Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Developmental Language Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Contextual Word Learning in Children With Developmental Language Disorder
RECRUITING · NA
-
Emergent Bilinguals: Child Language Proficiency and Language of Treatment
RECRUITING · NA
-
Neuroimaging Reveals Treatment-related Changes in DLD
RECRUITING · NA
-
The Short-term Verbal Memory Endophenotype for Developmental Language Disorder Language Disorder
RECRUITING · NA
-
A Developmental Framework For Linking Phonological And Morpho-syntactic Sequential Pattern Rules In DLD: Production
RECRUITING · NA
-
Optimizing Feedback-based Learning in Children With Developmental Language Disorder
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01174108 · 120 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
- NCT01627301 · 120 participants · NA
Sympathetic Overactivity in Post-traumatic Stress Disorder
- NCT02025023 · 120 participants · Phase 3
Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study
- NCT02128906 · 120 participants · Phase 2
Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI